vimarsana.com

Latest Breaking News On - Kevin danahy - Page 4 : vimarsana.com

Pulse Biosciences reports first use of pulsed-field ablation catheter

Pulse Biosciences (Nasdaq:PLSE) today announced the completion of the first-in-human procedures for its CellFX nsPFA cardiac catheter.

Pulse Biosciences Files 510(k) Submission with U S FDA for its CellFX nsPFA Percutaneous Electrode

21.11.2023 - Pulse Biosciences, Inc. (Nasdaq: PLSE), a company primarily focused on leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablation (nsPFA) technology for the treatment of atrial fibrillation, today announced the filing of a . Seite 1

Pulse Biosciences Shares Climb On Application for Percutaneous Electrode Review

By Sabela Ojea Shares of Pulse Biosciences jumped on Tuesday after the company said that it submitted a Food and Drug Administration premarket application for its CellFX nsPFA percutaneous.

Pulse Biosciences to Present at the 35th Annual Piper Sandler Healthcare Conference

Pulse Biosciences to Present at the 35th Annual Piper Sandler Healthcare Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.